Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Boucher

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Virus Eradication|November 23, 2019
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-savingStephanie Popping, Brooke Nichols, Bart Rijnders, et al.
Antiviral Therapy|June 7, 2013
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance NetworkDeenan Pillay, Jan Albert, Silvia Bertagnolio, et al.
BMJ Open|November 30, 2021
Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatmentMaartje Dijkstra, Henrieke Prins, Jan M Prins, et al.
Journal of Virus Eradication|July 28, 2018
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination frameworkStephanie Popping, Manal El-Sayed, Jordan Feld, et al.
Influenza and Other Respiratory Viruses|December 22, 2017
Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information StudyBruno Lina, Charles Boucher, Albert Osterhaus, et al.
Studies in Health Technology and Informatics|June 19, 2008
Multi-science decision support for HIV drug resistance treatmentPeter Sloot, Peter Coveney, Marian T Bubak, et al.
AIDS (London, England)|January 25, 2002
Clinical utility of HIV-1 genotyping and expert advice: the Havana trialCristina Tural, Lidia Ruiz, Christopher Holtzer, et al.
Plos One|April 20, 2016
The Role of Hospital Inpatients in Supporting Medication Safety: A Qualitative StudySara Garfield, Seetal Jheeta, Fran Husson, et al.
The International Journal of Pharmacy Practice|August 3, 2021
Medicines management at home during the COVID-19 pandemic: a qualitative study exploring the UK patient/carer perspectiveSara Garfield, Carly Wheeler, Charles Boucher, et al.
Plos One|July 9, 2016
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactDobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Virus Eradication|November 23, 2019
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-savingStephanie Popping, Brooke Nichols, Bart Rijnders, et al.
Antiviral Therapy|June 7, 2013
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance NetworkDeenan Pillay, Jan Albert, Silvia Bertagnolio, et al.
BMJ Open|November 30, 2021
Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatmentMaartje Dijkstra, Henrieke Prins, Jan M Prins, et al.
Journal of Virus Eradication|July 28, 2018
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination frameworkStephanie Popping, Manal El-Sayed, Jordan Feld, et al.
Influenza and Other Respiratory Viruses|December 22, 2017
Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information StudyBruno Lina, Charles Boucher, Albert Osterhaus, et al.
Studies in Health Technology and Informatics|June 19, 2008
Multi-science decision support for HIV drug resistance treatmentPeter Sloot, Peter Coveney, Marian T Bubak, et al.
AIDS (London, England)|January 25, 2002
Clinical utility of HIV-1 genotyping and expert advice: the Havana trialCristina Tural, Lidia Ruiz, Christopher Holtzer, et al.
Plos One|April 20, 2016
The Role of Hospital Inpatients in Supporting Medication Safety: A Qualitative StudySara Garfield, Seetal Jheeta, Fran Husson, et al.
The International Journal of Pharmacy Practice|August 3, 2021
Medicines management at home during the COVID-19 pandemic: a qualitative study exploring the UK patient/carer perspectiveSara Garfield, Carly Wheeler, Charles Boucher, et al.
Plos One|July 9, 2016
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactDobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, et al.
Pageof 5